|
Match
|
Document |
Document Title |
|
|
6177094 |
Bioabsorbable blends and coating composition containing same
A bioabsorbable blend is provided which comprises the reaction product of 1) a bioabsorbable copolymer obtained by polymerizing a major amount of epsilon-caprolactone and a minor amount of at least...
|
|
|
6177102 |
Once daily analgesic tablet
An analgesic controlled release dosage form containing: (a) 40-80 weight percent of an analgesic; (b) 10-30 weight percent of a pharmaceutically acceptable filler; and (c) 10-30 weight percent of a...
|
|
|
6168805 |
Aqueous process for manufacturing paroxetine solid dispersions
A process for preparing solid, amorphous paroxetine comprising: (A) mixing paroxetine free base or a pharmaceutically acceptable paroxetine salt with water and pharmaceutically acceptable polymer;...
|
|
|
6165482 |
Gastrointestinal drug composition
A composition for treating the gastrointestinal tract comprising a porous insoluble absorbent in which the pores of the insoluble absorbent are clogged by a coating material which causes the...
|
|
|
6156348 |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
Methods and compositions are provided for enhancing the bioadhesive properties of polymers used in drug delivery systems. The bioadhesive properties of a polymer are enhanced by incorporating an...
|
|
|
6149922 |
Vaccine adjuvant and vaccine
The present invention includes novel polyoxyethylene/polyoxypropylene block copolymers as well as methods for making the block copolymers. The block copolymers are high molecular weight molecules...
|
|
|
6150410 |
pH independent extended release pharmaceutical formulation
Pharmaceutical formulations of acidic pharmacologic agents which demonstrate improved uniformity of release over the wide range of pH values encountered between the stomach and intestinal tract...
|
|
|
6149940 |
Tablet with controlled release of alfuzosine chlorhydrate
Pharmaceutical tablet which consists of: a) a first layer having the property of swelling considerably and quickly on contact with aqueous biological fluids, the first layer being produced by...
|
|
|
6143315 |
Biochemical contact lens for treating injured corneal tissue
Methods for treating injured corneal tissue are described. The methods include contacting injured corneal tissue with a contact lens which includes an amniotic composition such that scarring of the...
|
|
|
6129931 |
Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
A pH-dependent, controlled-release, drug delivery composition is described herein which includes: (a) a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone, or their...
|
|
|
6126970 |
Cisapride sustained release
|
|
|
6124037 |
Articles coated with in vivo polymerizable ophthalmic compositions
Coatings for surgical instruments which comprise substituted fluoroalkyl or perfluoroalkyl monomers having anionic, cationic, and/or nonionic surface active functionality in the unsaturated...
|
|
|
6120781 |
Cosmetic or dermopharmaceutical composition in the form of a soft paste and process for preparing the said composition
The present invention relates to a cosmetic or dermopharmaceutical composition in the form of a soft paste, which can be used for making up or treating the skin or lips, comprising, in a fatty...
|
|
|
6120803 |
Prolonged release active agent dosage form adapted for gastric retention
The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid...
|
|
|
6120789 |
Non-polymeric sustained release delivery system
The invention relates to a method and composition for forming an implant in-situ within a body using non-polymeric materials, and the use of such implants as medical devices and drug delivery...
|
|
|
6117444 |
Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
A resorbable hemostatic agent comprising a delivery component, that aids in the delivery to the wound site, and a microfibrillar hemostatic component that controls bleeding in solid tissue and does...
|
|
|
6117451 |
Direct compression metformin hydrochloride tablets
Metformin Hydrochloride (herein referred to as metformin HCl) that may be 98.5%-100% pure is a high dose drug capable of being directly compressed with specific excipients into tablets having...
|
|
|
6110497 |
Pharmaceutical formulations
Tablet formulations having a structure comprising compacted granulates of a mixture of a medicament and an intra-granular disintegrant, the granulates being compacted together into a tablet with an...
|
|
|
6106863 |
Sustained-release metal valproate tablets
The present invention provides a sustained-release metal valproate tablet which is comparatively compact and is not influenced by a meal, the sustained-release metal valproate comprising a core...
|
|
|
6107344 |
Aqueous germicidal film forming composition for applying to teats of dairy cows
Aqueous film forming compositions are disclosed that are to be applied to the teats of dairy animals to form a protective film on the teats. The protective film may be applied as a dip or spray....
|
|
|
6103271 |
Microencapsulation and electrostatic processing method
Methods are provided for forming spherical multilamellar microcapsules having alternating hydrophilic and hydrophobic liquid layers, surrounded by flexible, semi-permeable hydrophobic or...
|
|
|
6103269 |
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
The invention relates to accurately meterable shaped articles, for example granules or pellets, containing hydrophilic macromolecules, active compounds and optionally further pharmaceutically...
|
|
|
6103264 |
Process for preparing a controlled release composition
A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with...
|
|
|
6083531 |
Fast disintegrating oral dosage form
|
|
|
6080793 |
Cosmetically/pharmaceutically/hygienically-active supple doughs comprising heat-sensitive compounds
Cosmetic/pharmaceutical/hygienic compositions (e.g., lipcolors) are formulated as homogeneous and stable, supple dough extrudates, said supple dough extrudates having at least one...
|
|
|
6080426 |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
A process for encapsulation of caplets in a capsule comprises the following steps: a. providing empty capsule parts; b. filling at least one of said capsule parts with one or more caplets; c....
|
|
|
6071536 |
Gelatin capsule having adjusted water activity
|
|
|
6066334 |
Use of redispersible polymer powders or polymer granules as binders for producing solid pharmaceutical presentations
Redispersible polymer powders or polymer granules consisting of a) 10-95% by weight of polyvinyl acetate, b) 5-90% by weight of an N-vinylpyrrolidone-containing polymer, c) 0-20% by weight...
|
|
|
6063406 |
Skin care compositions
The present invention includes a process and composition for treating skin disorders. The composition of the present invention comprises 94.0 to 99.2 percent by weight of cation-free water, 0.1 to...
|
|
|
6060547 |
Film forming foundation
The invention is a water-in-oil emulsion film forming foundation having a synergistic combination of about 0.5% to about 10% by weight of a water soluble or water dispersible film forming polymer,...
|
|
|
6054451 |
Analgesic composition and method for alleviating pain
The analgesic effectiveness of an analgesic selected from the group consisting of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine, (S)-5-(2-azetidinylmethoxy)-2-chloropyridine and pharmaceutically...
|
|
|
6051255 |
Polymer coated tablet comprising amoxycillin and clavulanate
The present invention is to a tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of...
|
|
|
6046243 |
Compositions for sustained release of a gas
A composite for retarding microbiological contamination containing a hydrophobic material containing an acid releasing agent, and a hydrophilic material containing anions that are capable of...
|
|
|
6037328 |
Method and composition for rewetting and preventing deposits on contact lens
The present invention is directed to an ophthalmic solution for the treatment of contact lenses while worn in the eye. In particular, the composition contains ethoxylated glucose derivative,...
|
|
|
6037387 |
Blood-compatible material of a supramolecular structure
A platelet metabolism suppressing blood compatible material has a supramolecular structure containing a plurality of cyclic compounds and a hydrophilic straight-chain polymer threading into...
|
|
|
6036946 |
Methods for protecting skin from damaging effects of ultraviolet light
A topical antioxidant composition for the protection of skin from damage caused by ultraviolet radiation. The composition includes a first component (such as beta glucan) that increases cellular...
|
|
|
6034175 |
Salts of peptides with carboxy-terminated polyesters
This invention relates to novel salts composed of a cation derived from a peptide containing at least one basic group and an anion derived from a carboxy-terminated polyester, processes for the...
|
|
|
6030644 |
Sustained-release granular preparations and production process thereof
This invention relates to sustained-release granular preparations obtained by wet-granulating an aqueous suspension, which comprises a medicinal ingredient, a fine particulate polymer having an...
|
|
|
6027748 |
Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
Described herein is a particular type of pharmaceutical tablet, for oral use, which is formed by one or more layers, and is specifically designed for controlled release of active principles that...
|
|
|
6027745 |
Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
A process for producing a controlled drug-release contact lens, containing a first member which forms a front fact of the lens and a second member which forms a rear face of the lens, the first and...
|
|
|
6024980 |
Multiphase soft gelatin dosage form
The present invention relates to a dosage form containing a common enclosure of polymeric material. The enclosure contains multiple phases of semi-solid fill materials containing active ingredients.
|
|
|
6015577 |
Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation
The specification describes a pharmaceutical combination consisting of dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing...
|
|
|
6013283 |
Alkyl or olefinic endcapped polyalkylene oxide solubilizer
A method for rendering water-insoluble materials water-soluble is provided. The method is useful for solubilizing substantially water-insoluble bioactive materials such as drugs. This is...
|
|
|
6010719 |
Freeze-dried disintegrating tablets
Freeze-dried disintegrating tablets, said tablets containing at least a therapeutic agent, a matrix forming agent and a binding agent, in which the tablets contain more than 20% by weight of a...
|
|
|
6007845 |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
Particles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified to achieve variable release rates or to...
|
|
|
6001386 |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
A simple and implantable sustained release drug delivery device with an inner core containing an effective amount of a low solubility agent covered by a non-bioerodible polymer coating layer that...
|
|
|
5980927 |
Method and apparatus for administering analgesics, and method for making same device
A device and method is disclosed for continuously administering an analgesic to the neuraxis of an organism. The device comprises a polymeric matrix body loaded with the analgesic. The body is...
|
|
|
5976521 |
Anti-acne cosmetic compositions
An anti-acne cosmetic composition in the form of a multiple phase water-in-oil emulsion and process for preparing thereof, wherein the composition comprises two or more aqueous phases and a...
|
|
|
5977183 |
Solid antimicrobial compositions
Substantially solid (or nonflowable) antimicrobial compositions have advantages over corresponding liquids and powders. Such a composition may be contained within a plastic bottle with a label...
|
|
|
5972381 |
Solid solution of an antifungal agent with enhanced bioavailability
A pharmaceutical composition in the form of a substantially amorphous solid solution comprising an antifungal compound of the formula I: ##STR1## wherein: X is F; and R 1 is ##STR2## or an ester...
|